BRIEF-Valeant CEO says is in touch with government on investigations

Mon Oct 19, 2015 8:35am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 19 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant CEO says generics with no competitors account for $75 million in revenues quarterly

* Valeant CEO says growth trend emphasizes volume, not pricing

* Valeant CEO says is in touch with government on investigations, declines further comment

* Valeant CEO says sees research and development becoming more of a focus, says with the stock at these prices it will consider share buybacks

* Valeant CEO defends pricing strategy saying many Wall Street analyst reports, media reports are wrong

* Valeant CEO says its patient assistance programs are administered by a reputable third party Further company coverage: (Reporting By Caroline Humer)